Waters Change in Assets/Liabilities 2010-2025 | WAT
Waters annual/quarterly change in assets/liabilities history and growth rate from 2010 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
- Waters change in assets/liabilities for the quarter ending March 31, 2025 was $0.097B, a 19.3% increase year-over-year.
- Waters change in assets/liabilities for the twelve months ending March 31, 2025 was $-0.223B, a 9.77% increase year-over-year.
- Waters annual change in assets/liabilities for 2024 was $-0.128B, a 22.38% decline from 2023.
- Waters annual change in assets/liabilities for 2023 was $-0.164B, a 140.79% increase from 2022.
- Waters annual change in assets/liabilities for 2022 was $-0.068B, a 123.91% increase from 2021.
| Waters Annual Change in Assets/Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $-128 |
| 2023 | $-164 |
| 2022 | $-68 |
| 2021 | $-31 |
| 2020 | $-95 |
| 2019 | $-58 |
| 2018 | $17 |
| 2017 | $501 |
| 2016 | $15 |
| 2015 | $0 |
| 2014 | $-13 |
| 2013 | $-6 |
| 2012 | $-10 |
| 2011 | $6 |
| 2010 | $18 |
| 2009 | $-5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $16.995B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.276B | 21.81 |
| Intuitive Surgical (ISRG) | United States | $171.420B | 71.05 |
| IDEXX Laboratories (IDXX) | United States | $52.185B | 54.31 |
| Edwards Lifesciences (EW) | United States | $45.166B | 29.93 |
| Alcon (ALC) | Switzerland | $42.434B | 28.68 |
| IQVIA Holdings (IQV) | United States | $31.605B | 17.86 |
| DexCom (DXCM) | United States | $31.439B | 47.16 |
| Mettler-Toledo (MTD) | United States | $26.632B | 31.61 |
| STERIS (STE) | Ireland | $24.008B | 25.55 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.710B | 0.00 |
| Hologic (HOLX) | United States | $15.113B | 16.37 |
| Penumbra (PEN) | United States | $9.693B | 70.81 |
| Sysmex ADR (SSMXY) | Japan | $8.813B | 28.00 |
| Globus Medical (GMED) | United States | $8.376B | 19.27 |
| Masimo (MASI) | United States | $8.156B | 27.45 |
| Teleflex (TFX) | United States | $5.287B | 8.53 |
| Glaukos (GKOS) | United States | $5.124B | 0.00 |
| TransMedics (TMDX) | United States | $4.470B | 67.94 |
| Integer Holdings (ITGR) | United States | $3.760B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.765B | 15.82 |
| Alphatec Holdings (ATEC) | United States | $2.326B | 0.00 |
| Veracyte (VCYT) | United States | $2.263B | 31.27 |
| PROCEPT BioRobotics (PRCT) | United States | $2.148B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.073B | 24.75 |
| Artivion (AORT) | United States | $2.069B | 104.40 |
| Elekta AB (EKTAY) | Sweden | $1.879B | 16.90 |
| Integra LifeSciences Holdings (IART) | United States | $1.073B | 6.15 |
| OPKO Health (OPK) | United States | $1.048B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.06 |
| Tandem Diabetes Care (TNDM) | United States | $0.750B | 0.00 |
| SiBone (SIBN) | United States | $0.656B | 0.00 |
| AxoGen (AXGN) | United States | $0.652B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.618B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.511B | 4.11 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.501B | 8.84 |
| OrthoPediatrics (KIDS) | United States | $0.492B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.413B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| Pacific Biosciences Of California (PACB) | United States | $0.363B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.348B | 8.85 |
| RxSight (RXST) | United States | $0.301B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.34 |
| Alpha Tau Medical (DRTS) | Israel | $0.276B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| CVRx (CVRX) | United States | $0.196B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.114B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.093B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| DarioHealth (DRIO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.80 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |